Marc Thibonnier, M.D., M.Sc.
Dr. Thibonnier is Founder, President, CEO, and member of the Board of Directors at AptamiR. He led a successful career in academic medicine, followed by ten years of leadership in drug development at Bayer, BMS and GSK, overseeing cardiovascular and metabolic drug development from candidate selection to regulatory approval. Dr. Thibonnier earned an M.D. at the Université Pierre et Marie Curie and a M.Sc. at the University of California, San Francisco. He currently holds an appointment as Clinical Professor of Medicine at Stanford University.
Mr. Camus is Chairman of the Board of Directors at AptamiR. He also holds the positions of Chairman of the Board at Alcatel-Lucent and Senior Advisor at Evercore Partners. Formerly, he was the CEO of EADS and co-managing partner at Lagardère. He holds degrees from Ecole Normale Supérieure and Institut d’Etudes Politiques de Paris.
Dr. Jean-Pierre Lehner
Dr. Jean-Pierre Lehner is a member of the Board of Directors at AptamiR. He is a cardiologist, and the retired Chief Medical Officer of Sanofi, with previous positions at Roussel, Roussel-UCLAF, and Sanofi Winthrop. Currently, he is CEO of JPL Pharma Consulting and a Board Member of several biotech and R&D companies. Dr. Lehner earned his M.D. at the University of Paris School of Medicine.